Literature DB >> 6124898

The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular transmission.

I MacKenzie, G Burnstock, J O Dolly.   

Abstract

The twitch response observed during low frequency electrical stimulation of postganglionic cholinergic neurones supplying the longitudinal smooth muscle of the guinea-pig ileum was markedly reduced by incubation with an homogeneous preparation of botulinum type A neurotoxin (4.3-8.6 nM). This intoxication of the autonomic cholinergic neurones was long-lasting, irreversible by washing, but readily reversed by 4-aminopyridine (50-1000 microM). The noradrenergic motor response of the rat anococcygeus following field stimulation was partially antagonised by the neurotoxin. The non-adrenergic inhibitory response of the guinea-pig taenia coli, elicited by field stimulation, was not antagonised by botulinum toxin, suggesting that a source of a non-adrenergic inhibitory transmitter exists, other than intramural cholinergic neurones. However, the neurogenic excitatory responses of the guinea-pig bladder, elicited by field stimulation in the presence of atropine and guanethidine, were virtually abolished by botulinum toxin. It is suggested that the parasympathetic neurones which supply the smooth muscle of the guinea-pig urinary bladder co-release acetylcholine and a non-cholinergic excitatory transmitter; ATP or polypeptides are possible candidates.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124898     DOI: 10.1016/0306-4522(82)90056-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  33 in total

1.  Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin.

Authors:  C Cuillière; P Ducrotté; F Zerbib; E H Metman; D de Looze; F Guillemot; H Hudziak; H Lamouliatte; J C Grimaud; A Ropert; M Dapoigny; R Bost; M Lémann; M A Bigard; P Denis; J L Auget; J P Galmiche; S Bruley des Varannes
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

Review 2.  Pannexin: from discovery to bedside in 11±4 years?

Authors:  Gerhard Dahl; Robert W Keane
Journal:  Brain Res       Date:  2012-07-04       Impact factor: 3.252

Review 3.  Botulinum A toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms.

Authors:  Catherine A Thomas; Yao-Chi Chuang; Antonella Giannantoni; Michael B Chancellor
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

4.  Botulinum toxin: poisoning the spastic bladder and urethra.

Authors:  Christopher P Smith; George T Somogyi; Michael B Chancellor
Journal:  Rev Urol       Date:  2002

Review 5.  Purinergic signalling in the reproductive system in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-23       Impact factor: 3.765

Review 6.  Non-adrenergic, non-cholinergic control of the urinary bladder.

Authors:  C H Hoyle
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

Review 7.  ATP release through pannexon channels.

Authors:  Gerhard Dahl
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

Review 8.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

9.  Botulinum toxin-A for idiopathic overactivity of the vesical detrusor: a 2-year follow-up.

Authors:  Stefanie Kuschel; Matthias Werner; Daniel Max Schmid; Elke Faust; Bernhard Schuessler
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-01-19

Review 10.  Purinergic mechanosensory transduction and visceral pain.

Authors:  Geoffrey Burnstock
Journal:  Mol Pain       Date:  2009-11-30       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.